CROX vs. CPRX
CROX (Crocs, Inc.) and CPRX (Catalyst Pharmaceuticals, Inc.) are both stocks. CROX operates in Footwear & Accessories (Consumer Cyclical), while CPRX operates in Biotechnology (Healthcare). Over the past 10 years, CROX returned 27.39%/yr vs 48.01%/yr for CPRX. At a 0.17 correlation, their price movements are largely independent.
Performance
CROX vs. CPRX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CROX achieves a 41.08% return, which is significantly higher than CPRX's 34.02% return. Over the past 10 years, CROX has underperformed CPRX with an annualized return of 27.39%, while CPRX has yielded a comparatively higher 48.01% annualized return.
CROX
- 1D
- 1.09%
- 1M
- 16.42%
- YTD
- 41.08%
- 6M
- 39.95%
- 1Y
- 18.91%
- 3Y*
- 1.26%
- 5Y*
- 2.78%
- 10Y*
- 27.39%
CPRX
- 1D
- 0.03%
- 1M
- 0.42%
- YTD
- 34.02%
- 6M
- 35.06%
- 1Y
- 20.91%
- 3Y*
- 39.11%
- 5Y*
- 40.76%
- 10Y*
- 48.01%
CROX vs. CPRX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CROX Crocs, Inc. | 41.08% | -21.92% | 17.26% | -13.85% | -15.43% | 104.63% | 49.58% | 61.24% | 105.54% | 84.26% |
CPRX Catalyst Pharmaceuticals, Inc. | 34.02% | 11.84% | 24.15% | -9.62% | 174.74% | 102.69% | -10.93% | 95.31% | -50.90% | 272.38% |
Correlation
The correlation between CROX and CPRX is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.23 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.26 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.29 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.24 |
Correlation (All Time) Calculated using the full available price history since Nov 9, 2006 | 0.17 |
The correlation between CROX and CPRX shifts across timeframes, from 0.17 (all time) to 0.29 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
CROX:
$6.12B
CPRX:
$3.97B
CROX:
-$1.94
CPRX:
$1.74
CROX:
1.60
CPRX:
6.67
CROX:
4.29
CPRX:
3.92
CROX:
$4.02B
CPRX:
$596.96M
CROX:
$2.34B
CPRX:
$378.23M
CROX:
$297.04M
CPRX:
$313.50M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CROX vs. CPRX — Risk / Return Rank
CROX
CPRX
CROX vs. CPRX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Crocs, Inc. (CROX) and Catalyst Pharmaceuticals, Inc. (CPRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| CROX | CPRX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.26 | ||
| Sortino ratioReturn per unit of downside risk | -0.25 | ||
| Omega ratioGain probability vs. loss probability | 1.13 | 1.14 | -0.01 |
| Calmar ratioReturn relative to maximum drawdown | 0.58 | 0.77 | -0.19 |
| Martin ratioReturn relative to average drawdown | 0.99 | 1.40 | -0.41 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| CROX | CPRX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.36 | 0.63 | -0.26 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.05 | 0.86 | -0.81 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.49 | 0.80 | -0.31 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.17 | 0.09 | +0.08 |
Drawdowns
CROX vs. CPRX - Drawdown Comparison
The maximum CROX drawdown since its inception was -98.74%, roughly equal to the maximum CPRX drawdown of -94.25%. Use the drawdown chart below to compare losses from any high point for CROX and CPRX.
Loading charts...
Drawdown Indicators
| CROX | CPRX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.74% | -94.25% | -4.49% |
Max Drawdown (1Y)Largest decline over 1 year | -32.54% | -27.29% | -5.25% |
Max Drawdown (3Y)Largest decline over 3 years | -54.04% | -27.29% | -26.75% |
Max Drawdown (5Y)Largest decline over 5 years | -73.86% | -45.37% | -28.49% |
Max Drawdown (10Y)Largest decline over 10 years | -75.18% | -64.87% | -10.31% |
Current DrawdownCurrent decline from peak | -33.18% | -0.16% | -33.02% |
Average DrawdownAverage peak-to-trough decline | -61.28% | -52.02% | -9.26% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 19.17% | 14.95% | +4.22% |
Volatility
CROX vs. CPRX - Volatility Comparison
Crocs, Inc. (CROX) has a higher volatility of 11.01% compared to Catalyst Pharmaceuticals, Inc. (CPRX) at 0.44%. This indicates that CROX's price experiences larger fluctuations and is considered to be riskier than CPRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CROX | CPRX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.01% | 0.44% | +10.57% |
Volatility (6M)Calculated over the trailing 6-month period | 31.82% | 23.50% | +8.32% |
Volatility (1Y)Calculated over the trailing 1-year period | 52.52% | 33.58% | +18.94% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 55.12% | 47.80% | +7.32% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 55.96% | 60.47% | -4.51% |
Dividends
CROX vs. CPRX - Dividend Comparison
Neither CROX nor CPRX has paid dividends to shareholders.
Financials
CROX vs. CPRX - Financials Comparison
This section allows you to compare key financial metrics between Crocs, Inc. and Catalyst Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CROX vs. CPRX - Profitability Comparison
CROX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Crocs, Inc. reported a gross profit of 522.95M and revenue of 921.46M. Therefore, the gross margin over that period was 56.8%.
CPRX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Catalyst Pharmaceuticals, Inc. reported a gross profit of 0.00 and revenue of 149.39M. Therefore, the gross margin over that period was 0.0%.
CROX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Crocs, Inc. reported an operating income of 200.84M and revenue of 921.46M, resulting in an operating margin of 21.8%.
CPRX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Catalyst Pharmaceuticals, Inc. reported an operating income of 73.23M and revenue of 149.39M, resulting in an operating margin of 49.0%.
CROX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Crocs, Inc. reported a net income of 137.56M and revenue of 921.46M, resulting in a net margin of 14.9%.
CPRX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Catalyst Pharmaceuticals, Inc. reported a net income of 63.73M and revenue of 149.39M, resulting in a net margin of 42.7%.
Frequently Asked Questions
CROX and CPRX have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CROX has higher volatility (11.01%) compared to CPRX (0.44%). In terms of maximum drawdown, CROX dropped -98.74% vs CPRX's -94.25%.
CPRX currently has the higher Sharpe Ratio (0.63 vs 0.36), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CROX and CPRX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer